PHARMACOKINETIC SUBSTANTIATION OF THE THERAPEUTIC EFFICACY OF ANTISEPTIC PREPARATION CYDIPOL IN TREATMENT OF PROSTATITIS

Kravchenko V. G., Ivanov L. V., Derimedved L. V., Shcherbak O. V.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

Improving the treatment of prostatitis is an urgent task, since many means and methods of treating this ailment do not always achieve the desired result, which is largely due to the topographic-anatomical features of the prostate gland and pathological changes in its gistostructures in the course of the disease. For Cidipol, taking into account its pharmacokinetic properties, it is possible to overcome tissue barriers, an experimental study of its therapeutic efficacy in prostatitis was quite reasonable. Мain goal of the research is to substantiate theoretically and experimentally the usage of Cydipol, a preparation with a broad spectrum of pharmacological activity for the treatment of prostatitis when applied rectally. Research methods were pharmacokinetic, gas and liquid chromatography, with rectal application of Cidipol to laboratory animals (rabbits), with further extrapolating of the results of previously obtained data on the study of preparations containing , as well as Cidipol, nitroxyl group (Ciminal and Nitazol) at rectal application Results and consideration. The pharmacokinetics of Cidipol is characterized by slow absorption of ciminial with a semi-absorption period for 1.1 hours, Tmax = 2.5 hours and rather slow removal of ciminal from animal’s body (T0.5 = 5.1 hours, Kel = 0.13). The effectiveness of the local method of administration of Cidipol directly depends on its lipophilicity and well-marked membrane-forming properties, which enable the preparation to quickly diffuse through the numerous cell membranes of the tissues. A significant amount of PEG 400 in the drug Cidipol provides maximum bioavailability of cimenal in the tissue of the prostate, rectum and colon. Findings. The specific pharmacokinetic profile and pharmacokinetic parameters of Cidipol for rectal application suggest that Cidipol has all the properties as a remedy in the form of suppositories, ointments or thick fluids for the treatment both prostatitis and colorectal diseases. Medicinal forms with Cidipol (suppositories, ointments, gels) can provide direct diffusion of pharmaceutical substance into the tissues of the prostate and the rectum mucus through the tissues of rectum mucous membrane, and not the systemic flow, based on the close proximity of the gland to the place of application of the drug. One can positively consider the prospects of the same dosage forms of Cidipol for the treatment of various cervicitis and vaginitis, including microbial-fungal. Cidipol should be considered as a holistic pharmaceutical system, in which there are no excipients, but there are only active ingredients that provide a significant contribution to the formation of the overall therapeutic efficacy of the complex.

pharmacokinetics, prostatitis, Cidipol, rectal administration, suppositories

1. Arnoldi ÉK. Khronycheskyy prostatyt: problemy, opyt, perspektyvy [monohrafyya]. Rostov na D.: «Fenyks»; 1999. 320 s. [in Russian].
2. Shchetynyn VV, Zotov EA. Prostatyt [nauchnaya monohrafyya]. M.: Medytsyna; 2003. 488 s. [in Russian].
3. Ivanov LV, Kravchenko VH. Doslidzhennya farmakokinetyky Cidipolu – antyseptychnoho zasobu z shyrokym spektrom farmakolohichnoyi diyi. Pryynyato do druku v «Ukr. zhurnal dermatolohiyi, venerolohiyi, kosmetolohiyi». 2018;4. [in Ukrainian].
4. Kravchenko VH, vynakhidnyk. Patent Ukrayiny № 104, 1992 r.; Patent Ros. Federatsyy № 1637807, 93 h.; Patent SSHA № 801, 444, Jan. 31, 1989, «Sredstvo dlya yndyvydualnoy profylaktyky venerycheskykh bolezney y lechenyya urohenytalʹnoho trykhomonyaza» Patent Ukrayiny № 112956, 10.11.2016 r. «Antyseptychnyy likarskyy zasib z shyrokym spektrom farmakolohichnoyi diyi» [in Ukrainian].
5. Bezshapochnyy SB, Kravchenko VH, Hryshyna IS. Mikozy zovnishnʹoho vukha ta yikh ratsionalʹne likuvannya. Zhurnal vushnykh, nosovykh i horlovykh khvorob. 2017;2:22-8. [in Ukrainian].
6. Kozak NV, Henyk BL, Torous IM, Prysyazhna SI. Cidipol v kompleksniy terapiyi istynnoyi mikhurnytsi. Mater. Vseukrayinskoyi naukovo-praktychnoyi konfer. molodykh uchenykh «Medychna nauka v praktyku okhorony zdorovya». Poltava, 2017. s. 27. [in Ukrainian].
7. Lebedyuk MM, Kravchenko VH, Zapolskyy EM, Lebedyuk KM. Eksperymentalne obgruntuvannya i klinichna otsinka protyvirusnykh vlastyvostey Cidipolu – antyseptychnoho likarskoho zasobu z shyrokym spektrom farmakolohichnoyi diyi. Ukrayinskyy zhurnal dermat., venerol., kosmetol. 2017;1(63):99-105. [in Ukrainian].
8. Litvin OS, Dashchuk AM, vynakhidnyky. Sposib likuvannya vuhrovoyi khvoroby v stadiyi zahostrennya, poyednanoyi iz dysbiozom kyshechnyku. Patent Ukrayiny na vynakhid № 115642 vid 27.11.2017. 5 s. [in Ukrainian].
9. Kravchenko VH, Khadzhay YaY, Lukashov SV, Levchenko VV. Éksperymentalnaya otsenka ostroy toksychnosty Cidipolu – preparata dlya yndyvydualnoy profylaktyky venerycheskykh bolezney. Dermatolohyya y venerolohyya. K.: «Zdorovya». 1988;23:94-7. [in Russian].
10. Kravchenko VH. Cidipol – Tsydypol. Іnformatsyonnye materyaly dlya zarubezhnoho patentovanyya (na anhl. y rus. yaz.). Poltava; 1992. 31 s. [in Russian].
11. Ivanov LV. Vivchennya biodostupnosti nitazolu u tkaninu peredmikhurovoі zalozi kroliv pri rektalnomu vvedenni іm pinnikh ayerozolív. Visnik farmatsii. Kharkiv. 1997;2(16):116-7. [in Ukrainian].
12. Ivanov LV. Izucheniye farmakokinetiki lekarstvennykh preparatov, soderzhashchikh nitazol. Farmakom. 1998;2:51-6. [in Russian].
13. Ivanov LV, Orlova IN. Biofarmatsevticheskiye issledovaniya, napravlennyye na optimizatsiyu sostava, svoystv i puti vvedeniya lekarstvennykh preparatov. V sb. «Tekhnologiya i standartizatsiya lekarstv», Khar’kov. 2000;2:558-615. [in Russian].
14. Ivanov LV. Membranotropnyye svoystva lekarstvennykh veshchestv. Problemy poiska, skrininga i biodostupnosti. Farmakom. 2004;2:78-83. [in Russian].
15. Ivanov LV, Kartel’ NT. Kharakterizatsiya reologicheskikh svoystv poverkhnosti nanobioobyektov metodom spinovykh zondov. Poverkhnost’. 2012;4(19):334-48. [in Russian].
16. Ivanov LV, Lyapunov NA, Orlova IN. Izucheniye biodostupnosti gidrokortizona atsetata pri rektal’nom vvedenii krolikam pennogo preparata. Khim. farm. zhurnal. 1993;27(12):29-31. [in Russian].
17. Dobretsov GE, Lyskovtsev VV, Vekshin NA. Svyaz’ mezhdu strukturoy, sredstvom k fosfolipidnym membranam i antiaritmicheskoy aktivnost’yu 10-tsiloaminopropionil’nykh proizvodnykh fenotiazina. Farmakol. i toksikol. 1979;2:23-6. [in Russian].
18. Mogilevich SE, Kul’chitskiy AG, Volovik ZN. Sravnitel’naya kharakteristika vzaimodeystviya nekotorykh nesteroidnykh protivovospalitel’nykh sredstv s biomembranami pri eksperimental’nom vospalenii. Farmakol. i toksikol. 1989;52(4):59-61. [in Russian].
19. Reznikov KM, Isayeva GA, Isayev PP. Osobennosti molekulyarnykh mekhanizmov deystviya mestnoanesteziruyushchikh sredstv. KH Rossiyskiy natsional’nyy kongress: Chelovek i lekarstvo. Tezisy dokladov. M., 2003. s. 653. [in Russian].
20. Martynova TI, Dul’tsev YUV. Primeneniye preparatov propolisa v proktologii. Propolis, «Apimondiya», Bukharest, 1980. s. 133-5. [in Russian].
21. Orkin VF. Propolis v terapii khronicheskogo prostatita. Propolis, «Apimondiya», Bukharest, 1980. s. 142. [in Russian].
22. Semina IG, Semina II, Azangeyev NM. K voprosu o membrannykh mekhanizmakh deystviya nootropnykh preparatov. Biologiya membrany. 2001;18(5):363-9. [in Russian].
23. Pankrusheva TA, Zubova SN, Nesterova AV. Biofarmatsevticheskiye aspekty v razrabotke sostava i tekhnologii suppozitoriyev s metronidazolom. X Rossiyskiy natsional’nyy kongress: Chelovek i lekarstvo. Tez. dokl. M., 2003. s. 644. [in Russian].
24. Kravchenko VG, Dashchuk AM. Antibіotikorezistentnіst’ і mіstsevі antiseptichnі lіkars’kі zasobi yak medichna problema. Aktual’nі pitannya dermatologіі, venerologіі, і VІL/SNІD іnfektsіі: Zbіrnik naukovikh prats’. Kh.: Vodniy spektr; 2018. s. 12-9. [in Ukrainian].
25. Salmanov AG. Antimіkrobna rezistentnіst’ ta іnfektsіі, asotsіyovanі z medichnoyu dopomogoyu v Ukraіnі [monografíya]. Kiуv, 2015. 451 s. [in Ukrainian].

«Bulletin of problems biology and medicine» Issue 4 Part 2 (147), 2018 year, 143-148 pages, index UDK 615.28.015:616.65-002-085

10.29254/2077-4214-2018-4-2-147-143-148